Assertio Holdings, Inc. (ASRT): Nasdaq/NYSE listing notice — Assertio Holdings receives Nasdaq delisting notice for bid price below $1.00

Assertio Holdings, Inc.

Received Nasdaq notice on Feb 21, 2024, because common stock bid price closed below $1.00 for 30 consecutive business days.
Has 180 calendar days (until Aug 19, 2024) to regain compliance by closing at $1.00+ for 10 consecutive business days.
If not compliant by deadline, may be eligible for additional 180-day period; company may consider reverse stock split.
No immediate delisting; the Notice does not affect current trading on Nasdaq.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

Assertio Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

February 21, 2024, Assertio Holdings, Inc. (the “Company”) received notification (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company’s common stock is subject to potential delisting from the Nasdaq Capital Market because, for a period of 30 consecutive business days, the bid price of the Company’s common stock has closed below the minimum $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). The Notice does not result in the immediate delisting of the Company’s commo

View on SEC.gov

8 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Assertio Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-027093

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.